Madrigal Pharmaceuticals
MDGL
MDGL
53 hedge funds and large institutions have $120M invested in Madrigal Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.56% more ownership
Funds ownership: 16.82% → 21.39% (+4.6%)
Holders
53
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24.9M | |
| 2 | +$4.5M | |
| 3 | +$3.31M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.88M |
| 5 |
Renaissance Technologies
New York
|
+$2.33M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$4.5M | |
| 3 | -$3.15M | |
| 4 |
Citigroup
New York
|
-$185K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$64K |